IDO1 and renal cell carcinoma: Animal studies have shown that IFN-γ induced IDO1 restricted tumour growth [53, 54] and while clinical studies have shown that hepatocellular and renal cell carcinoma specimens evidenced a positive association between IDO1 expression and favourable outcomes [55, 56].